Literature DB >> 26241753

Kinetics of drug release from ointments: Role of transient-boundary layer.

Xiaoming Xu1, Manar Al-Ghabeish2, Yellela S R Krishnaiah3, Ziyaur Rahman4, Mansoor A Khan5.   

Abstract

In the current work, an in vitro release testing method suitable for ointment formulations was developed using acyclovir as a model drug. Release studies were carried out using enhancer cells on acyclovir ointments prepared with oleaginous, absorption, and water-soluble bases. Kinetics and mechanism of drug release was found to be highly dependent on the type of ointment bases. In oleaginous bases, drug release followed a unique logarithmic-time dependent profile; in both absorption and water-soluble bases, drug release exhibited linearity with respect to square root of time (Higuchi model) albeit differences in the overall release profile. To help understand the underlying cause of logarithmic-time dependency of drug release, a novel transient-boundary hypothesis was proposed, verified, and compared to Higuchi theory. Furthermore, impact of drug solubility (under various pH conditions) and temperature on drug release were assessed. Additionally, conditions under which deviations from logarithmic-time drug release kinetics occur were determined using in situ UV fiber-optics. Overall, the results suggest that for oleaginous ointments containing dispersed drug particles, kinetics and mechanism of drug release is controlled by expansion of transient boundary layer, and drug release increases linearly with respect to logarithmic time. Published by Elsevier B.V.

Entities:  

Keywords:  Acyclovir; Higuchi model; In vitro drug release; Kinetics; Logarithmic time release; Ointment; Transient-boundary

Mesh:

Substances:

Year:  2015        PMID: 26241753     DOI: 10.1016/j.ijpharm.2015.07.077

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

Review 1.  Perspectives on Physicochemical and In Vitro Profiling of Ophthalmic Ointments.

Authors:  Quanying Bao; Diane J Burgess
Journal:  Pharm Res       Date:  2018-10-15       Impact factor: 4.200

2.  Influence of Manufacturing Process Variables on the Properties of Ophthalmic Ointments of Tobramycin.

Authors:  Shilpa Patere; Bryan Newman; Yan Wang; Stephanie Choi; Sahil Vora; Anson W K Ma; Michael Jay; Xiuling Lu
Journal:  Pharm Res       Date:  2018-07-25       Impact factor: 4.200

3.  Ophthalmic delivery of hydrophilic drugs through drug-loaded oleogels.

Authors:  Russell Macoon; Anuj Chauhan
Journal:  Eur J Pharm Sci       Date:  2020-11-01       Impact factor: 4.384

4.  Mechanistic analysis of Zein nanoparticles/PLGA triblock in situ forming implants for glimepiride.

Authors:  Osama Abdelhakim Aly Ahmed; Ahmed Samir Zidan; Maan Khayat
Journal:  Int J Nanomedicine       Date:  2016-02-03

5.  Improved solubility and corneal permeation of PEGylated curcumin complex used for the treatment of ophthalmic bacterial infections.

Authors:  Muhammad Hanif; Nabeela Ameer; Qurat-Ul-Ain Ahmad; Mubashir Aziz; Khalid Mahmood; Nasreen Ramzan; Hafiz Muhammad Abdur Rahman
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.240

6.  Influence of Concentration on Release and Permeation Process of Model Peptide Substance-Corticotropin-From Semisolid Formulations.

Authors:  Wioletta Siemiradzka; Barbara Dolińska; Florian Ryszka
Journal:  Molecules       Date:  2020-06-15       Impact factor: 4.411

7.  Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations.

Authors:  Maxime Le Merdy; Jessica Spires; Viera Lukacova; Ming-Liang Tan; Andrew Babiskin; Xiaoming Xu; Liang Zhao; Michael B Bolger
Journal:  Pharm Res       Date:  2020-11-19       Impact factor: 4.200

8.  Preparation and In Vivo Evaluation of a Lidocaine Self-Nanoemulsifying Ointment with Glycerol Monostearate for Local Delivery.

Authors:  Ji-Hyun Kang; Kwang-Hwi Yoo; Hyo-Young Park; Seung-Min Hyun; Sang-Duk Han; Dong-Wook Kim; Chun-Woong Park
Journal:  Pharmaceutics       Date:  2021-09-14       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.